jrnl1987

Publication Venue For

  • Effector TH17 Cells Give Rise to Long-Lived TRM Cells that Are Essential for an Immediate Response against Bacterial Infection.  178:1176-1188.e15. 2019
  • Phenotypic Landscape of Schizophrenia-Associated Genes Defines Candidates and Their Shared Functions.  177:478-491.e20. 2019
  • Megabase Length Hypermutation Accompanies Human Structural Variation at 17p11.2.  176:1310-1324.e10. 2019
  • Pharmacological Targeting of STK19 Inhibits Oncogenic NRAS-Driven Melanomagenesis.  176:1113-1127.e16. 2019
  • Activated PMN Exosomes: Pathogenic Entities Causing Matrix Destruction and Disease in the Lung.  176:113-126.e15. 2019
  • Erratum: Comprehensive Characterization of Cancer Driver Genes and Mutations (ARTICLE (2018) 173(2) (371–385), (S009286741830237X), (10.1016/j.cell.2018.02.060)).  174:1034-1035. 2018
  • Erratum: Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer (Cell (2017) 171(3) (540–556.e25) (S0092867417310565) (10.1016/j.cell.2017.09.007)).  174:1033. 2018
  • Genomic Dissection of Bipolar Disorder and Schizophrenia, Including 28 Subphenotypes.  173:1705-1715.e16. 2018
  • A Pan-Cancer Analysis of Enhancer Expression in Nearly 9000 Patient Samples.  173:386-399.e12. 2018
  • An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics.  173:400-416.e11. 2018
  • Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.  173:291-304.e6. 2018
  • Comprehensive Characterization of Cancer Driver Genes and Mutations.  173:371-385.e18. 2018
  • Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation.  173:338-354.e15. 2018
  • Oncogenic Signaling Pathways in The Cancer Genome Atlas.  173:321-337.e10. 2018
  • Pathogenic Germline Variants in 10,389 Adult Cancers.  173:355-370.e14. 2018
  • Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics.  173:305-320.e10. 2018
  • Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas.  171:950-965.e28. 2017
  • Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer.  171:540-556.e25. 2017
  • Development of a Novel Lead that Targets M. tuberculosis Polyketide Synthase 13.  170:249-259.e25. 2017
  • Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma.  169:1327-1341.e23. 2017
  • An Organismal CNV Mutator Phenotype Restricted to Early Human Development.  168:830-842. 2017
  • Chemical Hybridization of Glucagon and Thyroid Hormone Optimizes Therapeutic Impact for Metabolic Disease.  167:843-857.e14. 2016
  • Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy.  167:397-404.e9. 2016
  • Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma.  164:550-563. 2016
  • Evolving New Skeletal Traits by cis-Regulatory Changes in Bone Morphogenetic Proteins.  164:45-56. 2016
  • Jagged 1 Rescues the Duchenne Muscular Dystrophy Phenotype.  163:1204-1213. 2015
  • Daughter's Tolerance of Mom Matters in Mate Choice.  162:467-469. 2015
  • Identification of Genetic Factors that Modify Clinical Onset of Huntington's Disease.  162:516-526. 2015
  • Neuronal activity promotes glioma growth through neuroligin-3 secretion.  161:803-816. 2015
  • Snap Shot: Sensing and signaling by cilia.  161:692-692.e1. 2015
  • Advancing biological understanding and therapeutics discovery with small-molecule probes.  161:1252-1265. 2015
  • Integrated Genomic Characterization of Papillary Thyroid Carcinoma.  159:676-690. 2014
  • Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin.  158:929-944. 2014
  • Ribosomal protein s15 phosphorylation mediates LRRK2 neurodegeneration in parkinson's disease.  157:472-485. 2014
  • Potentiated Hsp104 variants antagonize diverse proteotoxic misfolding events.  156:170-182. 2014
  • Tryptophan biosynthesis protects mycobacteria from CD4 T-Cell-mediated Killing.  155:1296-1308. 2013
  • The somatic genomic landscape of glioblastoma.  155:462. 2013
  • XSpatial and temporal mapping of de novo mutations in schizophrenia to a fetal prefrontal cortical network.  154. 2013
  • Dwelling on T cell fate decisions.  153:739-741. 2013
  • Three-dimensional architecture of the rod sensory cilium and its disruption in retinal neurodegeneration.  151:1029-1041. 2012
  • A validated regulatory network for Th17 cell specification.  151:289-303. 2012
  • Erratum: Generation of isogenic pluripotent stem cells differing exclusively at two early onset parkinson point mutations (Cell (2011) 146 (318-331)).  146:659. 2011
  • Generation of isogenic pluripotent stem cells differing exclusively at two early onset parkinson point mutations.  146:318-331. 2011
  • Gaucher disease glucocerebrosidase and α-synuclein form a bidirectional pathogenic loop in synucleinopathies.  146:37-52. 2011
  • Glioma stem cell proliferation and tumor growth are promoted by nitric oxide synthase-2.  146:53-66. 2011
  • Cellular strategies for regulating DNA supercoiling: A single-molecule perspective.  142:519-530. 2010
  • Insulin Receptor Signaling in Osteoblasts Regulates Postnatal Bone Acquisition and Body Composition.  142:309-319. 2010
  • NF1 Is a Tumor Suppressor in Neuroblastoma that Determines Retinoic Acid Response and Disease Outcome.  142:218-229. 2010
  • Role for IGFBP7 in senescence induction by BRAF.  141:746-747. 2010
  • miR-328 Functions as an RNA Decoy to Modulate hnRNP E2 Regulation of mRNA Translation in Leukemic Blasts.  140:652-665. 2010
  • Human TUBB3 Mutations Perturb Microtubule Dynamics, Kinesin Interactions, and Axon Guidance.  140:74-87. 2010
  • PI3 Kinase Signals BCR-Dependent Mature B Cell Survival.  139:573-586. 2009
  • NPR1 in Plant Defense: It's Not over 'til It's Turned over.  137:804-806. 2009
  • Oncogenic BRAF Induces Senescence and Apoptosis through Pathways Mediated by the Secreted Protein IGFBP7.  132:363-374. 2008
  • Stem Cells on Patrol.  131:842-844. 2007
  • FOXP3 is an X-linked breast cancer suppressor gene and an important repressor of the HER-2/ErbB2 oncogene..  129:1275-1286. 2007
  • CHD5 Is a Tumor Suppressor at Human 1p36.  128:459-475. 2007
  • Nef-Mediated Suppression of T Cell Activation Was Lost in a Lentiviral Lineage that Gave Rise to HIV-1.  125:1055-1067. 2006
  • Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte.  123:321-334. 2005
  • Decoding Dopamine Signaling.  122:153-155. 2005
  • Mechanisms of conformational change for a replicative hexameric helicase of SV40 large tumor antigen.  119:47-60. 2004
  • DksA: A critical component of the transcription initiation machinery that potentiates the regulation of rRNA promoters by ppGpp and the initiating NTP.  118:311-322. 2004
  • Comparative genomics identifies a flagellar and basal body proteome that includes the BBS5 human disease gene.  117:541-552. 2004
  • O-GlcNAc modification is an endogenous inhibitor of the proteasome.  115:715-725. 2003
  • Identification of a Wnt/Dvl/β-Catenin → Pitx2 Pathway Mediating Cell-Type-Specific Proliferation during Development.  111:673-685. 2002
  • Drosophila fragile x-related gene regulates the MAP1B homolog Futsch to control synaptic structure and function.  107:591-603. 2001
  • Crystal structure of constitutive endothelial nitric oxide synthase: A paradigm for pterin function involving a novel metal center.  95:939-950. 1998
  • Thrombospondin-1 is a major activator of TGF-β1 in vivo.  93:1159-1170. 1998
  • Ectopically expressed CAG repeats cause intranuclear inclusions and a progressive late onset neurological phenotype in the mouse.  91:753-763. 1997
  • Association of the origin recognition complex with heterochromatin and HP1 in higher eukaryotes.  91:311-323. 1997
  • Targeted disruption of the melanocortin-4 receptor results in obesity in mice.  88:131-141. 1997
  • Identification of an ER retrieval signal in a retroviral glycoprotein.  82:543-544. 1995
  • Liddle's syndrome: Heritable human hypertension caused by mutations in the β subunit of the epithelial sodium channel.  79:407-414. 1994
  • A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes.  72:971-983. 1993
  • Transferrin receptor internalization sequence YXRF implicates a tight turn as the structural recognition motif for endocytosis.  63:1061-1072. 1990
  • Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNALys mutation.  61:931-937. 1990
  • Genetic linkage of von Recklinghausen neurofibromatosis to the nerve growth factor receptor gene.  49:589-594. 1987
  • Rearrangement of antigen receptor genes is defective in mice with severe combined immune deficiency.  46:963-972. 1986
  • Uncoating ATPase is a member of the 70 kilodalton family of stress proteins.  45:3-13. 1986
  • Expression of hemolytically active murine fourth component of complement in transfected L cells.  37:569-576. 1984
  • Four unique genes required for β tubulin expression in vertebrates.  32:713-724. 1983
  • Histone gene clusters of the newt notophthalmus are separated by long tracts of satellite DNA.  24:639-647. 1981
  • Identification of the gene and mRNA for the adenovirus terminal protein precursor.  23:497-508. 1981
  • SV40 gene expression is modulated by the cooperative binding of T antigen to DNA.  25:373-384. 1981
  • Identification and mapping of the transcriptional and translational products of the yeast plasmid, 2μ circle.  16:827-839. 1979
  • A supplementary adenoviral leader sequence and its role in messenger translation.  15:511-526. 1978
  • The spliced structures of adenovirus 2 fiber message and the other late mRNAs.  15:497-510. 1978
  • A map of cytoplasmic RNA transcripts from lytic adenovirus type 2, determined by electron microscopy of RNA:DNA hybrids.  11:819-836. 1977
  • An amazing sequence arrangement at the 5′ ends of adenovirus 2 messenger RNA.  12:1-8. 1977
  • Gene expression in chemically transformed mouse embryo cells: Selective enhancement of the expression of C type RNA tumor virus genes.  11:909-921. 1977